In this study, we systematically evaluated the expression profile and methylation status as well as its clinical relevance of the EphA5 gene in prostate cell lines, benign prostatic hyperplasia, primary human prostate tumors, and paired noncancerous tissues. The gene discussed is EPHA5; the disease is benign prostatic hyperplasia.